Oscar Health (OSCR) said on its Q3 earnings conference call that while it is too early to provide formal guidance, “we have taken appropriate actions to ensure we can deliver meaningful margin expansion and return to profitability next year.” The company said its 2026 pricing strategy balances growing market share and improving profitability.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OSCR: